About HotSpot Therapeutics
HotSpot Therapeutics news and updates
Excelra Knowledge Solutions Pvt Ltd partnered with HotSpot Therapeutics, Inc on May 25th 22'.
HYDERABAD, India and BOSTON, May 25, 2022 /PRNewswire/ -- Excelra, a leading global data and digital insights organization, today announced a partnership with HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune diseases.
Jan 1, 2022 | devdiscourse.comHotSpot Therapeutics, Inc hired Paul Thibodeau as Chief Business Officer on Jun 25th 22'.
HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune diseases, today announced the appointment of Paul Thibodeau, Ph.D., as Chief Business Officer.
Jan 1, 2022 | salesandmarketingnetwork.comHotSpot Therapeutics, Inc hired Jose "Pepe" Carmona as Board of Directors on Jul 19th 22'.
HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune diseases, today announced the appointment of Jose "Pepe" Carmona to its Board of Directors.
Jul 19, 2022 | prnewswire.comAbbVie Inc. partners with HotSpot Therapeutics, Inc
AbbVie ( ABBV ) is collaborating with Hotspot Therapeutics to license its discovery-stage IRF5 drug to treat autoimmune diseases.
Dec 6, 2022 | investors.comAbbVie Inc. partners with HotSpot Therapeutics, Inc
AbbVie ( ABBV ) is collaborating with Hotspot Therapeutics to license its discovery-stage IRF5 drug to treat autoimmune diseases.
Dec 6, 2022 | investors.comHotSpot Therapeutics, Inc is developing small-molecule interferon regulatory factor 5 inhibitors to treat cancer and autoimmune diseases on Nov 6th 22'.
HotSpot will use its technology, Smart Allostery, a drug discovery platform, to develop small-molecule interferon regulatory factor 5 (IRF5) inhibitors to treat cancer and autoimmune diseases.
Dec 6, 2022 | pharmafile.com